Vivek Narayan Selected Research

PH 797804

1/2018

Inhibition of p38 MAPK in combination with ART reduces SIV-induced immune activation and provides additional protection from immune system deterioration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vivek Narayan Research Topics

Disease

18	Neoplasms (Cancer) 01/2022 - 02/2012
10	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2017
7	Breast Neoplasms (Breast Cancer) 01/2022 - 07/2017
7	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 01/2016
5	Urinary Bladder Neoplasms (Bladder Cancer) 10/2019 - 05/2015
5	Acquired Immunodeficiency Syndrome (AIDS) 01/2018 - 11/2008
4	Inflammation (Inflammations) 01/2018 - 01/2010
3	Heart Failure 01/2021 - 01/2018
3	Infections 12/2020 - 08/2011
3	Hypertension (High Blood Pressure) 01/2018 - 01/2016
3	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2017 - 12/2016
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017 - 01/2016
2	Cardiotoxicity 01/2022 - 07/2017
2	Second Primary Neoplasms (Neoplasms, Second) 01/2022 - 01/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2020
2	Viremia 12/2020 - 01/2018
2	Carcinoma (Carcinomatosis) 10/2019 - 01/2019
2	HIV Infections (HIV Infection) 01/2018 - 11/2008
1	Sepsis (Septicemia) 01/2022
1	Cytokine Release Syndrome 01/2022
1	Hematologic Neoplasms (Hematological Malignancy) 01/2022
1	Periodontitis 09/2021
1	Insulin Resistance 09/2021
1	Sarcoma (Soft Tissue Sarcoma) 01/2021
1	Vaccinia 12/2020
1	Disease Progression 12/2020
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2020
1	Left Ventricular Dysfunction 01/2018
1	Persistent Infection 01/2018
1	Hyperplasia 12/2017
1	Adenocarcinoma in Situ 12/2017
1	Adenocarcinoma 12/2017
1	Glioblastoma (Glioblastoma Multiforme) 11/2017
1	Meningioma (Meningiomas) 01/2017
1	Lung Injury 01/2017

Drug/Important Bio-Agent (IBA)

10	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2016
6	Trastuzumab (Herceptin)FDA Link 01/2022 - 07/2017
5	AndrogensIBA 12/2021 - 05/2019
4	Cisplatin (Platino)FDA LinkGeneric 10/2019 - 05/2015
4	SeleniumIBA 08/2015 - 11/2008
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 07/2017
3	AnthracyclinesIBA 01/2022 - 01/2019
3	Prostate-Specific Antigen (Semenogelase)IBA 01/2022 - 01/2017
3	Immune Checkpoint InhibitorsIBA 01/2021 - 10/2019
3	Sunitinib (Sutent)FDA Link 01/2021 - 07/2017
2	cabozantinibIBA 01/2021 - 01/2019
2	Carboplatin (JM8)FDA LinkGeneric 01/2020 - 10/2019
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2019 - 01/2018
2	Complement System Proteins (Complement)IBA 07/2011 - 08/2009
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2022
1	Chimeric Antigen ReceptorsIBA 01/2022
1	abirateroneIBA 01/2022
1	Aryldialkylphosphatase (Paraoxonase)IBA 01/2022
1	arylesteraseIBA 01/2022
1	acetyl- 2- naphthylalanyl- 3- chlorophenylalanyl- 1- oxohexadecyl- seryl- 4- aminophenylalanyl(hydroorotyl)- 4- aminophenylalanyl(carbamoyl)- leucyl- ILys- prolyl- alaninamide FDA Link 10/2021
1	Leuprolide (Lupron)FDA LinkGeneric 10/2021
1	Blood Glucose (Blood Sugar)IBA 09/2021
1	Glucose (Dextrose)FDA LinkGeneric 09/2021
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 09/2021
1	1- (1- (imidazo(1,2- a)pyridin- 6- yl)ethyl)- 6- (1- methyl- 1H- pyrazol- 4- yl)- 1H- (1,2,3)triazolo(4,5- b)pyrazineIBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021
1	Proto-Oncogene Proteins c-metIBA 01/2021
1	human ERBB2 proteinIBA 01/2021
1	Proteasome InhibitorsIBA 01/2021
1	CrizotinibIBA 01/2021
1	VaccinesIBA 12/2020
1	E coli heat-labile enterotoxinIBA 12/2020
1	GP 140IBA 12/2020
1	DNA (Deoxyribonucleic Acid)IBA 12/2020
1	NivolumabIBA 10/2020
1	IpilimumabIBA 10/2020
1	Docetaxel (Taxotere)FDA Link 01/2020
1	pro-brain natriuretic peptide (1-76)IBA 01/2019
1	p38 Mitogen-Activated Protein KinasesIBA 01/2018
1	InterferonsIBA 01/2018
1	CytokinesIBA 01/2018
1	PH 797804IBA 01/2018
1	Antiviral Agents (Antivirals)IBA 01/2018
1	Bevacizumab (Avastin)FDA Link 11/2017
1	Arginine (L-Arginine)FDA Link 07/2017
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2017
1	CitrullineIBA 07/2017
1	Biological ProductsIBA 01/2017
1	Metformin (Glucophage)FDA LinkGeneric 01/2017
1	TOR Serine-Threonine KinasesIBA 01/2017
1	AMP-Activated Protein KinasesIBA 01/2017

Therapy/Procedure

18	Therapeutics 10/2021 - 11/2008
6	Drug Therapy (Chemotherapy) 01/2020 - 12/2016
4	Radiotherapy 05/2019 - 01/2016
4	Neoadjuvant Therapy 01/2017 - 05/2015
3	Castration 01/2022 - 10/2020
3	Immunotherapy 01/2022 - 10/2019
2	Cystectomy 01/2018 - 07/2016
2	Salvage Therapy 01/2017 - 12/2016
1	Brachytherapy 05/2019
1	Nephrectomy 01/2019
1	Secondary Prevention 07/2017
1	Precision Medicine 01/2017
1	Prostatectomy (Retropubic Prostatectomy) 01/2017